CompletedPhase 2NCT00651066

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Studying Primary genito-urinary tuberculosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Principal Investigator
Anthony D. Harries, PhD
The international Union Against Tuberculosis and Lung Diseases (IUATLD), Paris, France
Intervention
rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1(drug)
Enrollment
47 target
Eligibility
18-65 years · All sexes
Timeline
20102012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00651066 on ClinicalTrials.gov

Other trials for Primary genito-urinary tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Primary genito-urinary tuberculosis

← Back to all trials